Healthcare -
Biotechnology - NASDAQ - US
$ 11.535
-1.49 %
$ 467 M
Market Cap
-2.21
P/E
KROS - TOTAL RECEIVABLES
Total Receivables KROS - Keros Therapeutics, Inc.
1.09 M
LAST VALUE
-75.38%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR